MedTrace Logo

Orange Juice And Sugar Intervention Study

NCT03527277 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2025-11-10

Study results available
· View outcomes & findings →

Summary

The objectives of this proposal are to address the gaps in knowledge regarding the metabolic effects of consuming orange juice, the most frequently consumed fruit juice in this country, compared to sugar-sweetened beverage.

Conditions

  • Cardiovascular Risk Factor
  • Type2 Diabetes Mellitus
  • Insulin Sensitivity
  • Metabolic Syndrome

Interventions

OTHER

Naturally-sweetened orange juice

Commercially-available ready-to-serve refrigerated orange juice

OTHER

Sugar-sweetened beverage

Sugar-sweetened water flavored with Kool-Aid (TM)

Sponsors & Collaborators

  • Touro University, California

    collaborator OTHER

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Kimber L Stanhope, Ph.D. · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2023-05-28
Completion
2023-05-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03527277 on ClinicalTrials.gov